Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12,498,551
-
Total 13F shares
-
736,630
-
Share change
-
+729,819
-
Total reported value
-
$4,120,236
-
Price per share
-
$5.59
-
Number of holders
-
23
-
Value change
-
+$4,082,162
-
Number of buys
-
21
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q3 2024
As of 30 Sep 2024 Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 736,630 shares of stock of the company.
Largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, BVF INC/IL, PERCEPTIVE ADVISORS LLC, FRED ALGER MANAGEMENT, LLC, Cable Car Capital LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 23 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.